148 related articles for article (PubMed ID: 25468320)
61. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
[TBL] [Abstract][Full Text] [Related]
62. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
Behl D; Ristow K; Markovic SN; Witzig TE; Habermann TM; Colgan JP; Inwards DJ; White WL; Ansell SM; Micallef IN; Johnston PB; Porrata LF
Br J Haematol; 2007 Jun; 137(5):409-15. PubMed ID: 17433025
[TBL] [Abstract][Full Text] [Related]
63. Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Kim JE; Kim CW; Huh J
Am J Clin Pathol; 2012 Dec; 138(6):846-54. PubMed ID: 23161719
[TBL] [Abstract][Full Text] [Related]
64. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
[TBL] [Abstract][Full Text] [Related]
65. Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.
Huang YC; Liu CY; Lu HJ; Liu HT; Hung MH; Hong YC; Hsiao LT; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Tzeng CH; Yu YB
Ann Hematol; 2013 Nov; 92(11):1513-20. PubMed ID: 23775580
[TBL] [Abstract][Full Text] [Related]
66. Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal.
Kleber M; Ihorst G; Udi J; Koch B; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):38-48. PubMed ID: 22054851
[TBL] [Abstract][Full Text] [Related]
67. Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells.
Liu Y; Chen W; Yu M; Li H; Cheng H; Cao J; Yan Z; Shi M; Zhu F; Sun H; Sang W; Li D; Wu Q; Chen C; Zheng J; Xu K; Li Z
Transplant Cell Ther; 2022 Feb; 28(2):118.e1-118.e5. PubMed ID: 34861455
[TBL] [Abstract][Full Text] [Related]
68. Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
Hirase S; Hasegawa D; Takahashi H; Moriwaki K; Saito A; Kozaki A; Ishida T; Yanai T; Kawasaki K; Yamamoto N; Kubokawa I; Mori T; Hayakawa A; Nishimura N; Nishio H; Iijima K; Kosaka Y
Int J Hematol; 2015 Nov; 102(5):594-601. PubMed ID: 26440971
[TBL] [Abstract][Full Text] [Related]
69. Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma.
Kim DS; Yu ES; Kang KW; Lee SR; Park Y; Sung HJ; Choi CW; Kim BS
Korean J Intern Med; 2017 Jul; 32(4):711-721. PubMed ID: 27809455
[TBL] [Abstract][Full Text] [Related]
70. [Prediction of infections within 6 months of the initial diagnosis in adults with immune thrombocytopenia by absolute lymphocyte count].
Lyu M; Li Y; Liu W; Fu R; Sun T; Lyu C; Yang R
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):34-8. PubMed ID: 25641143
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma.
Shin SJ; Roh J; Kim M; Jung MJ; Koh YW; Park CS; Yoon DH; Suh C; Park CJ; Chi HS; Huh J
Korean J Pathol; 2013 Dec; 47(6):526-33. PubMed ID: 24421845
[TBL] [Abstract][Full Text] [Related]
72. The independent association of mean platelet volume with overall survival in multiple myeloma.
Zhuang Q; Xiang L; Xu H; Fang F; Xing C; Liang B; Yu K; Feng J
Oncotarget; 2016 Sep; 7(38):62640-62646. PubMed ID: 27566590
[TBL] [Abstract][Full Text] [Related]
73. Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience.
Khouri J; Dima D; Li H; Hansen D; Sidana S; Shune L; Anwer F; Sborov D; Wagner C; Kocoglu MH; Atrash S; Voorhees P; Peres L; Hovanky V; Simmons G; Williams L; Raza S; Afrough A; Anderson L; Ferreri C; Hashmi H; Davis J; McGuirk J; Goldsmith S; Borogovac A; Lin Y; Midha S; Nadeem O; Locke FL; Baz R; Hamilton B; Alsina M; Sauter C; Patel K; Kaur G
Transplant Cell Ther; 2024 Jun; ():. PubMed ID: 38834151
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
Jung SH; Kim JS; Lee WS; Oh SJ; Ahn JS; Yang DH; Kim YK; Kim HJ; Lee JJ
Ann Hematol; 2016 Jan; 95(1):55-61. PubMed ID: 26467916
[TBL] [Abstract][Full Text] [Related]
75. Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer.
Cho O; Oh YT; Chun M; Noh OK; Hoe JS; Kim H
Head Neck; 2016 Apr; 38 Suppl 1():E1061-7. PubMed ID: 26040623
[TBL] [Abstract][Full Text] [Related]
76. Substratification of patients with newly diagnosed standard-risk multiple myeloma.
Binder M; Rajkumar SV; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Hwa YL; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kyle RA; Kumar SK
Br J Haematol; 2019 Apr; 185(2):254-260. PubMed ID: 30768679
[TBL] [Abstract][Full Text] [Related]
77. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials.
Chen D; Verma V; Patel RR; Barsoumian HB; Cortez MA; Welsh JW
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):196-203. PubMed ID: 32036004
[TBL] [Abstract][Full Text] [Related]
78. Absolute lymphocyte count as a predictor of mortality in emergency department patients with paraquat poisoning.
Kang C; Kim SC; Lee SH; Jeong JH; Kim DS; Kim DH
PLoS One; 2013; 8(10):e78160. PubMed ID: 24205140
[TBL] [Abstract][Full Text] [Related]
79. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents.
Romano A; Laura Parrinello N; Cerchione C; Letizia Consoli M; Parisi M; Calafiore V; Martino E; Conticello C; Di Raimondo F; Alberto Palumbo G
Blood Cancer J; 2017 Dec; 7(12):649. PubMed ID: 29242558
[No Abstract] [Full Text] [Related]
80. Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis.
Li X; Han Z; Cheng Z; Yu J; Yu X; Liang P
Onco Targets Ther; 2014; 7():1829-35. PubMed ID: 25336974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
